Restenosis
Predictors
Plasma
monocyte chemoattractant protein-1 antigen levels and the risk of restenosis
after coronary stent implantation.
Oshima S, Ogawa H, Hokimoto S, Nakamura
S, Noda K, Saito T, Soejima H, Takazoe K, Ishibashi F, Yasue H.
Jpn Circ J 2001;65:261-4
Role of
cytokines in the pathogenesis of restenosis after percutaneous transluminal
coronary angioplasty.
Tashiro H, Shimokawa H, Sadamatsu K,
Aoki T, Yamamoto K.
Coron Artery Dis 2001;12:107-13
Increased
plasma antigen levels of monocyte chemoattractant protein-1 in patients with
restenosis after percutaneous transluminal coronary angioplasty.
Hokimoto S, Ogawa H, Saito T, Oshima S,
Noda K, Soejima H, Takazoe K, Date H, Ishibashi F, Nakamura S, Yasue H.
Jpn Circ J 2000;64:831-4
Histologic
comparison of coronary and iliac atherectomy tissue from cases of in-stent
restenosis.
Ishibashi-Ueda H, Yutani C, Imakita M,
Kuribayashi S, Takamiya M, Uchida H, Kichikawa K, Suzuki T.
Angiology 1999;50:977-87
Histologic
evidence of foreign body granulation tissue and de novo lesions in patients
with coronary stent restenosis.
Yutani C, Ishibashi-Ueda H, Suzuki T,
Kojima A.
Cardiology 1999;92:171-7
Deposition
of PG-M/versican is a major cause of human coronary restenosis after
percutaneous transluminal coronary angioplasty.
Matsuura R, Isaka N, Imanaka-Yoshida K,
Yoshida T, Sakakura T, Nakano T.
J Pathol 1996;180:311-6
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8958811&dopt=Abstract
Abstracts from international scientific meeting
Increased
monocyte chemoattractant protein-1 (MCP-1) expression in atherectomy specimens
from patients with restenosis after percutaneous transluminal coronary
angioplasty (PTCA) (AHA2000)
http://www.cct.gr.jp/abstra/b0134.html
P-selectin
expression and modification of CD36 on circulating platelets are good
predictors for restenosis after coronary stenting (AHA1999)
http://www.cct.gr.jp/abstra/b0124.html
Final
resistance of the target lesion is a strong predictor of the needs for repeat
revascularization: Assessment by a novel coronary hemodynamic index, epicardial
resistance ratio (ER), obtained by intracoronary pressure measurements
(AHA1999)
http://www.cct.gr.jp/abstra/b0126.html
Increased
plasma antigen levels of monocyte chemoattractant protein-1 (MCP-1) in patients
with high grade restenosis during chronic phase post coronary stent
implantation (AHA1999)
http://www.cct.gr.jp/abstra/b0129.html
Role of
hepatocyte growth factor in patients with coronary artery diseases (ACC1999)
http://www.cct.gr.jp/abstra/b0056.html
Role of
hepatocyte growth factor in percutaneous transluminal coronary balloon
angioplasty (ACC1999)
http://www.cct.gr.jp/abstra/b0057.html
Relationship
between serum hepatocyte growth factor level and restenosis after percutaneous
coronary angioplasty (ESC1998)
http://www.cct.gr.jp/abstra/b0044.html
Target
sites escaped from high-grade restenosis after percutaneous transluminal
coronary angioplasty: Do they become stable plaque? –Angiographical
reevaluation of more than one year interval (ACC1998)
http://www.cct.gr.jp/abstra/b0075.html
Treatment
Efficacy
of cutting balloon angioplasty for in-stent restenosis: an intravascular
ultrasound evaluation.
Muramatsu T, Tsukahara R, Ho M, Ito Y,
Hirano K, Ishimori H, Matushita M, Nakano M.
J Invasive Cardiol 2001;13:439-44
Repeat
intervention for in-stent restenosis: re-expansion of the initial stent is a
predictor of recurrence of restenosis.
Ishikawa S, Asakura Y, Okabe T,
Sakamoto M, Shibata M, Asakura K, Mitamura H, Ogawa S.
Coron Artery Dis 2000;11:451-7
Intravascular
ultrasound-guided balloon angioplasty for treatment of in-stent restenosis.
Sakamoto T, Kawarabayashi T, Taguchi H,
Tanaka A, Nishida Y, Shimada K, Yoshikawa J.
Catheter Cardiovasc Interv
1999;47:298-303
Transluminal
extraction atherectomy for restenosis following Palmaz-Schatz stent implantation.
Hara K, Ikari Y, Tamura T, Yamaguchi T.
Am J Cardiol 1997;79:801-2
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9070566&dopt=Abstract
Abstracts from international scientific meeting
Can low
molecular heparin dalteparin inhibit in-stent neointimal hyperplasia following
repeated PTCA to treat in-stent restenosis? A randomized trial followed by serial
IVUS analysis (ACC2001)
http://www.cct.gr.jp/abstra/b0103.html
Prevention
Pharmacological prevention
Effects
of cilostazol on late lumen loss and repeat revascularization after
Palmaz-Schatz coronary stent implantation.
Kozuma K, Hara K, Yamasaki M, Morino Y,
Ayabe S, Kuroda Y, Tanabe K, Ikari Y, Tamura T.
Am Heart J 2001;141:124-30
Troglitazone
reduces neointimal tissue proliferation after coronary stent implantation in
patients with non-insulin dependent diabetes mellitus: a serial intravascular
ultrasound study.
Takagi T, Akasaka T, Yamamuro A, Honda
Y, Hozumi T, Morioka S, Yoshida K.
J Am Coll Cardiol 2000;36:1529-35
The
Potential of Cilostazol in Interventional Cardiology.
Tsuchikane E, Kobayashi T, Awata N.
Curr Interv Cardiol Rep
2000;2:143-8
Impact of
cilostazol on restenosis after percutaneous coronary balloon angioplasty.
Tsuchikane E, Fukuhara A, Kobayashi T,
Kirino M, Yamasaki K, Kobayashi T, Izumi M, Otsuji S, Tateyama H, Sakurai M,
Awata N.
Circulation 1999;100:21-6
Impact of
tranilast on restenosis after coronary angioplasty: tranilast restenosis
following angioplasty trial (TREAT).
Tamai H, Katoh O, Suzuki S, Fujii K,
Aizawa T, Takase Si, Kurogane H, Nishikawa H, Sone T, Sakai K, Suzuki T.
Am Heart J 1999;138:968-75
Effects
of cilostazol on late lumen loss after Palmaz-Schatz stent implantation.
Yamasaki M, Hara K, Ikari Y, Kobayashi
N, Kozuma K, Ohmoto Y, Oh-Hashi Y, Ako J, Nakajima H, Chiku N, Saeki F, Tamura
T.
Cathet Cardiovasc Diagn
1998;44:387-91
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9716201&dopt=Abstract
Effects
of probucol and cilostazol alone and in combination on frequency of
poststenting restenosis.
Sekiya M, Funada J, Watanabe K,
Miyagawa M, Akutsu H.
Am J Cardiol 1998;82:144-7
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9678282&dopt=Abstract
Impact of
cilostazol on intimal proliferation after directional coronary atherectomy.
Tsuchikane E, Katoh O, Sumitsuji S,
Fukuhara A, Funamoto M, Otsuji S, Tateyama H, Awata N, Kobayashi T.
Am Heart J 1998;135:495-502
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9506336&dopt=Abstract
Use of
cilostazol, a novel antiplatelet agent, in a post-Palmaz-Schatz stenting
regimen.
Ochiai M, Isshiki T, Takeshita S, Eto
K, Toyoizumi H, Sato T, Miyashita H.
Am J Cardiol 1997;79:1471-4
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9185635&dopt=Abstract
Preventive
effects of probucol on restenosis after percutaneous transluminal coronary
angioplasty.
Watanabe K, Sekiya M, Ikeda S, Miyagawa
M, Hashida K.
Am Heart J 1996;132:23-9
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8701872&dopt=Abstract
Abstracts
from international scientific meeting
Impact of
cilostazol on 1-year clinical outcome following percutaneous coronary
angioplasty for patients with multivessel diseases (ESC2000)
http://www.cct.gr.jp/abstra/b0063.html
Cilostazol
inhibits intimal hyperplasia after implantation of Multi-Link stent; An
intravascular ultrasound study (ESC2000)
http://www.cct.gr.jp/abstra/b0004.html
Tranilast
reduces arterial wall cell proliferation after balloon angioplasty in pig
coronary arteries (ACC2000)
http://www.cct.gr.jp/abstra/b0090.html
Troglitazone
reduces intimal hyperplasia after coronary stent implantation in patients with
type 2 diabetes mellitus: A serial intravascular ultrasound study (ACC1999)
http://www.cct.gr.jp/abstra/b0081.html
Impact of
cilostazol on restenosis following percutaneous coronary angioplasty for
diabetics (ACC1999)
http://www.cct.gr.jp/abstra/b0048.html
Mechanisms
of reduction restenosis after coronary balloon angioplasty by cilostazol
(ACC1999)
http://www.cct.gr.jp/abstra/b0050.html
Comparison
of cilostazol with ticlopidine after Palmaz-Shatz stent implantation. A
prospective randomized study (AHA1998)
http://www.cct.gr.jp/abstra/b0071.html
Impact of
cilostazol on late lumen loss following percutaneous transluminal coronary
angioplasty assessed by serial intravascular ultrasound (ESC1998)
http://www.cct.gr.jp/abstra/b0041.html
Impact of
cilostazol on neointimal proliferation following Palmaz-Schatz stent
implantation: A prospective randomized trial (ACC1998)
http://www.cct.gr.jp/abstra/b0043.html
Tranilast
is more effective on restenotic lesion than de novo lesion for prevention of
restenosis (ACC1998)
http://www.cct.gr.jp/abstra/b0017.html
Effects
of cilostazol on restenosis after Palmaz-Schatz coronary stent implantation
(ACC1998)
http://www.cct.gr.jp/abstra/b0072.html
Tranilast
inhibits neointima formation in balloon-injured and stented pig coronary
arteries, and decreases negative remodeling after balloon injury (ACC1998)
http://www.cct.gr.jp/abstra/b0073.html
Mechanical prevention
Intravascular
sonotherapy decreases neointimal hyperplasia after stent implantation in swine.
Fitzgerald PJ, Takagi A, Moore MP,
Hayase M, Kolodgie FD, Corl D, Nassi M, Virmani R, Yock PG.
Circulation 2001;103:1828-31
Intramural
delivery of a specific tyrosine kinase inhibitor with biodegradable stent
suppresses the restenotic changes of the coronary artery in pigs in vivo.
Yamawaki T, Shimokawa H, Kozai T,
Miyata K, Higo T, Tanaka E, Egashira K, Shiraishi T, Tamai H, Igaki K,
Takeshita A.
J Am Coll Cardiol 1998;32:780-6
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9741527&dopt=Abstract
Abstracts
from international scientific meeting
Beneficial
effects of comprehensive cardiac rehabilitation and exercise training programs
on restenosis in patients with coronary artery disease after coronary stenting
(AHA2000)
http://www.cct.gr.jp/abstra/b0143.html
Quantitative
angiographic analysis of restenosis of primary stenting using Wiktor stent for
acute myocardial infarcion: Results from a multicenter randomized PRISAM study
(AHA1999)
http://www.cct.gr.jp/abstra/b0028.html
Beneficial
effects of comprehensive cardiac rehabilitation and exercise training programs
on restenosis in patients with coronary artery disease after coronary stenting
(AHA1998)
http://www.cct.gr.jp/abstra/b0020.html